Lee's Pharmaceutical Holdings Ltd. announced that Dr. Giuseppe Bianchi has joined the company as Chief Scientific Officer Lee's and CVie Therapeutics Company Limited. He is present and past member of the Editorial Boards of 12 international journals and invited speaker or chairman at more than 500 national and international meetings. Giuseppe Bianchi, MD, PhD pharmacology, Hon.

MD Universities of Berlin and Upsala, is Hon. member of the Alpha Omega Alpha Medical Society CA U.S.A., Italian societies of hypertension, U.S.A. National Kidney Foundation and other scientific organizations. He is also Professor Emeritus at the “Vita Salute” S. Raffaele University, and Scientific Director of the Prassis Sigma-Tau cardiovascular research institute.

He has published more than 300 articles in peer-review journals including high impact journals such as Nature, Science Trans. Med., New England Journal of Medicine and Lancet and more than 200 chapters or reviews in books. Over the years, Prof. Bianchi has combined his academic and clinical experience with parallel work in collaboration with pharmaceutical companies (Lepetit S.p.A., Farmitalia Carlo Erba, and Sigma-Tau S.p.A.) in order to develop a targeted therapeutic approach to cardiovascular diseases through laboratory and in clinical practice.